Competitive Intelligence Consultants in the Healthcare Sector

Our healthcare sector track record is measured by completing over 100 studies on behalf of biotech, medical device and pharma companies in Canada and the US.

We focus on 3 areas:

  • Conducting market opportunity assessments.
  • Gathering intelligence on a competitor’s launch initiatives.
  • Providing insights into how competitors will counter the client’s launch.

In These Studies We Blend Research To Generate Deeper Analysis And Greater Understanding

A woman doctor takes a phone call. We offer competitive intelligence services in the healthcare sector.

1. Association Interviews

2. Competitor Interviews

3. Drug Wholesaler Interviews

4. Industry Analyst Interviews

5. Online & Secondary Research

6. Patient Interviews

7. Physician Interviews

8. Supplier Interviews

9. Trial Support Staff Interviews

Therapeutic Areas Investigated

  • Acid Reflux Disease
  • Allergy
  • Anaesthesia
  • Anemia
  • Anticoagulants
  • Asthma
  • Birth Control
  • Broad-Spectrum Antibiotics
  • Car T Cell
  • Cardiovascular
  • Central Nervous System
  • Cholesterol
  • Chronic Renal Disease
  • Colorectal Cancer
  • COPD
  • Dermatology
  • Diabetes
  • Epilepsy
  • Erectile Dysfunction
  • Gastrointestinal
  • Generic Threats
  • Growth Hormones
  • Haemophilia
  • Hypertension
  • Incontinence
  • Lung Cancer
  • Migraines
  • Multiple Melanoma
  • Multiple Sclerosis
  • Obesity
  • Oncology
  • Osteoporosis
  • Pain Management
  • Pandemic Vaccines
  • Postmenopausal Hormone Therapy
  • Prostate Cancer
  • Testosterone

Key Intelligence Questions For The Healthcare Sector

We build each study from a list of Key Intelligence Questions. For example, a study investigating a competitor’s launch would address the following questions:

Clinical TrialsAre any trials taking place or being planned? If so: What cities? What is the focus? When will they take place?
DelaysAre they facing any delays? If so what?
DosageWhat dosages will be available at launch? Will the competitor be adding additional dosages after launch? If so what will these be?
Pre-Launch ActivityWhat advisory boards, conferences, medical meetings etc. are being planned? What about CHE events?
IndicationsWhat will the indications be at launch? What, if any, additional indications will be approved after launch?
KOLsWho are some of the KOLs the competitor is planning to work with? In what capacity?
Medical LiaisonHow many Medical Liaison Reps will they have? Will they be fully dedicated to the new product?
Patient SupportWhat home care programs and patient training are they planning?
SalesHow many sales reps will support the product? How many will be detailing the drug in 1st position? 2nd position?
SpendingWhat is an estimate of total marketing dollars to support the launch? What is the breakout between consumer and trade spending?
SubmissionHave they submitted an application for notice of compliance? If so, when do they anticipate receiving approval?
Target AudienceWhat will the sales message be? Which patient groups will they target?

Client Feedback

“Market Alert has a unique way of peeling back the layers of data to reveal insights that are not always obvious and can only be revealed by years of experience of asking the right questions and the questions that many others didn’t think to ask.”

Tom Handel Chief Commercial Officer at Meridian Medical Technologies

“David takes a disciplined, market research approach to conducting competitive intelligence in health sciences. He is very detailed, analytical and over delivers to ensure expectations are met. What impresses me the most is his perseverance. He never gives up until he finds the answer or gains the information.”

Terry Cully, Managing Director at Ogilvy CommonHealth

“David and his team were professional, timely with their work and very thorough. They were easy to work with and clearly worked to meet the needs of the business.”

Lisa Mullett, Chief Commercial Officer, Sunovion Pharmaceuticals

“I recently worked with David on a pharmaceutical competitive intelligence project. He was extremely professional, responsive, and easy to work with. Ultimately, the project met its objective and the entire team was pleased with David’s work. I would definitely recommend Market Alert, and will continue to use David’s services in the future.”

Aaron Mendaglio, Health Ecosystem & Futures Partner at Roche